drugset / Trial / NCT03742193
Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is to evaluate the efficacy and safety of Second-line chemotherapy combined with Apatinib for the patients with resectable pulmonary metastasis of osteosarcoma.
Timeline
- Start
- 2019-08-11
- Primary completion
- 2023-11-15
- Completion
- 2023-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 75 mg/m2 | — |
| Subject | Gemcitabine | Small molecule | 900 mg/m2 | — |
| Subject | Rivoceranib | Small molecule | 250 mg | Oral |